ConductScience.org, home

Paper7679331

Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer.

Smith DC and 7 others. Cancer Chemother Pharmacol, 1993. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer. Papers, record 7679331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7679331

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1993
PubMed
Publication types
Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.17
iCite
Revised in PubMed
2026-10-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith DCD C
2Jodrell DID I
3Egorin MJM J
4Ambinder RMR M
5Zuhowski EGE G
6Kreis WW
7Ellis PGP G
8Trump DLD L

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelphalanMajor topic
Prostatic NeoplasmsMajor topic
Aged
Aged, 80 and over
Chromatography, High Pressure Liquid
Half-Life
Hormones
Humans
Infusions, Intravenous
Male
Middle Aged
Prostate-Specific Antigen

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
5T32-CA-09307NCI NIH HHSUnited StatesT32CA009307PubMed and NIHNIH RePORTER
P30-A-14236-18PHS HHSUnited StatesPubMedPubMed
U10-CA-44691NCI NIH HHSUnited StatesU10CA044691PubMed and NIHNIH RePORTER

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1498,715Oral melphalan kinetics.Clin Pharmacol Ther1979https://conductscience.org/library/papers/498715PubMed
2445,500Melphalan in metastatic cancer of the prostate: a pilot study.Cancer Treat Rep1979https://conductscience.org/library/papers/445500PubMed
33,948,304Pharmacokinetics of high-dose melphalan in children and adults.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3948304PubMed
41,371,564Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer.J Urol1992https://conductscience.org/library/papers/1371564PubMed
56,861,266Pharmacokinetics of melphalan in children following high-dose intravenous injection.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6861266PubMed
6630,199Prednimustine therapy for advanced prostatic cancer.Br J Urol1978https://conductscience.org/library/papers/630199PubMed
7125,803Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate.J Urol1975https://conductscience.org/library/papers/125803PubMed
8365,313Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.Cancer1978https://conductscience.org/library/papers/365313PubMed
9736,979Amino acid-conferred protection against melphalan--characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells.Biochem Pharmacol1978https://conductscience.org/library/papers/736979PubMed
104,053,270High dose melphalan in children with advanced malignant disease. A pharmacokinetic study.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/4053270PubMed
111,984,806Cancer statistics, 1991.CA Cancer J Clin1991https://conductscience.org/library/papers/1984806PubMed
12762,115Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro.J Biol Chem1979https://conductscience.org/library/papers/762115PubMed
136,840,181The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous/oral study using a conventional dose regimen.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6840181PubMed
144,585,929Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate.Cancer1973https://conductscience.org/library/papers/4585929PubMed
15125,624The chemotherapy of urologic cancer.Cancer1975https://conductscience.org/library/papers/125624PubMed
163,396,150Lack of effect of cisplatin on i.v. L-PAM plasma pharmacokinetics in ovarian cancer patients.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3396150PubMed
177,427,921A comparison of melphalan transport in human breast cancer cells and lymphocytes in vitro.Cancer Lett1980https://conductscience.org/library/papers/7427921PubMed
183,516,430Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 cases.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3516430PubMed
193,719,900Renal function in the elimination of oral melphalan in patients with multiple myeloma.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3719900PubMed
206,436,700Leuprolide versus diethylstilbestrol for metastatic prostate cancer.N Engl J Med1984https://conductscience.org/library/papers/6436700PubMed

See all 47 references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7679331

GET https://conductscience.org/api/papers/v1/7679331/references?page=2